Search

everythinglearnresearchcommunity

for

Search:↓

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

Minoxidil can reduce functions related to androgen receptors.

Researchers created a cell line to study hair growth and found specific genes affected by dihydrotestosterone.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

Human skin can produce steroids from cholesterol.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Hair loss in androgenetic alopecia may be due to ongoing tiny inflammation and tissue changes around hair follicles.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Future acne treatments should aggressively target inflammation to prevent scarring.

Baicalin may help reduce excessive male hormone levels in PCOS.

Differences in androgen receptor expression and tissue properties may lead to higher cryptorchidism risk in certain rats.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

The conclusion is that understanding how hair follicle stem cells live or die is important for maintaining healthy tissue and repairing injuries, and could help treat hair loss, but there are still challenges to overcome.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Minoxidil may work for hair loss by reducing androgen sensitivity and altering hormone-related enzymes.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.